Molecular genetics of metastasis

Area of Science:

• Cancer Biology and Genetics
• Oncology
• Molecular Oncology

Background:

• Metastasis, the spread of cancer, is a complex process involving genetic and epigenetic alterations.
• Understanding the genetic basis of metastasis is crucial for developing effective cancer therapies.
• Previous research has explored various factors influencing tumor progression and gene expression.

Purpose of the Study:

• To identify genes and genetic alterations responsible for cancer metastasis.
• To investigate the role of oncogenes and genomic DNA transfer in conferring metastatic properties.
• To examine the influence of specific agents on tumor cell metastatic capability.

Main Methods:

• Introduction of activated oncogenes (e.g., c-Ha-ras 1) into non-neoplastic cells.
• Transfection of genomic DNA from highly metastatic to non-metastatic tumor cells.
• Treatment of tumor cells with agents like 12-O-tetradecanoylphorbol-13-acetate and 2'-deoxy-5-azacytidine.

Main Results:

• Activated rasH oncogene conferred tumorigenicity and lung colonization but not spontaneous metastasis.
• Genomic DNA transfer from metastatic cells augmented metastatic capability and extrapulmonary spread.
• Azacytidine and 12-O-tetradecanoylphorbol-13-acetate treatments significantly increased metastatic behavior.
• Metastatic phenotype changes were heritable, suggesting alterations in gene expression.
• Tumor cell dissemination patterns were influenced by the tissue of origin and host organ interactions.

Conclusions:

• Components of the metastatic phenotype are heritable, conserved, and can be conferred by genomic DNA transfer.
• Metastasis involves acquired abnormalities in tumor cell gene regulation.
• Host organ microenvironments can modulate or inhibit secondary tumor formation.